Vycor Medical (VYCO) Long-Term Investments (2024 - 2026)

Vycor Medical (VYCO) has reported Long-Term Investments for 3 consecutive years, with $39777.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Long-Term Investments fell 46.58% year-over-year to $39777.0 in Q2 2026; TTM through Jun 2026 was $39777.0, a 46.58% decrease from a year earlier, with the FY2025 full-year figure at $71779.0, down 5.68% from the prior year.
• Long-Term Investments was $39777.0 for Q2 2026 at Vycor Medical, up from $38101.0 in the prior quarter.
• Over five years, Long-Term Investments peaked at $76105.0 in Q4 2024 and troughed at $38101.0 in Q1 2026.
• A 3-year average of $60351.6 and a median of $65729.0 in 2025 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments slipped 5.68% in 2025 and sank 46.58% in 2026, its largest moves.
• Over 3 years, Long-Term Investments stood at $76105.0 in 2024, then declined by 5.68% to $71779.0 in 2025, then tumbled by 44.58% to $39777.0 in 2026.
• The last three Long-Term Investments figures came in at $39777.0 (Q2 2026), $38101.0 (Q1 2026), and $71779.0 (Q4 2025), per Business Quant data.